Légalisation CBD

CBD legalization

May 03, 2023Manu N.

The legalization of CBD is a subject that gives rise to numerous debates and questions, not only in France, but also in Belgium. Since its discovery, this non-psychoactive molecule from the cannabis plant has been subject to specific regulations in several countries around the world.

In France, the situation remains quite vague despite recent advances in legislation. But then, what is it really? Is the legalization of CBD in 2023 really a reality or just an unfounded rumor? And in Belgium, what are the rules in force regarding CBD?

In this article, we will explain everything you need to know about the legalization of CBD planned for 2023 in France and the current situation in Belgium. We will discuss the various legal and regulatory aspects related to this issue as well as the potential impact it could have on the market for products containing CBD in these two countries. Prepare to be informed and enlightened on this complex subject!

What is CBD?

Cannabidiol, or CBD , is one of the molecules present in cannabis. Unlike tetrahydrocannabinol ( THC ), another cannabis molecule, CBD does not have psychotropic effects and does not cause a feeling of euphoria in consumers. CBD can be extracted from different parts of the cannabis plant, such as flowers, leaves or hemp.

Until recently, French legislation considered that all products containing CBD were narcotics prohibited for sale and consumption.

However, since December 2020, an order has been issued to authorize “the production, manufacturing (…) and marketing” of certain products containing CBD in France under certain specific conditions linked in particular to their THC content.

Also at the European level, there have been recent developments regarding CBD regulations. In November 2020, for example, the European Union decided that no restrictions could be placed on raw hemp flowers if they respect a maximum level of 0.2% THC.

Today, many people recognize its health benefits as well as its economic importance in certain sectors such as food for its variety of possible uses (despite certain resistance).

What are the effects of CBD?

CBD is a molecule found in cannabis and hemp that does not have the psychotropic effects associated with THC. Many consumers use CBD products for its soothing and anti-inflammatory properties, although these effects have yet to be scientifically proven.

In France, the regulations around CBD have long been vague, but since December 2020, a ministerial decree authorizes the marketing of certain varieties of raw hemp flowers containing less than 0.2% THC. However, the use of CBD remains subject to legal restrictions in other European countries.

CBD products are considered food supplements in France and cannot be sold as medicines without authorization. Companies that produce or sell products containing CBD must respect the maximum THC content authorized by French law.

Although some have expressed concerns about the potentially negative effects of CBD on mental or physical health, it appears that it is generally safe for regular use in healthy adults. However, potential consumers are always recommended to obtain professional advice before use.

As the legality around CBD is still relatively new in several European and American countries (particularly in Belgium), it is important for consumers to be informed about local regulations before using products based on this molecule.

Is CBD legal?

The legality of CBD varies by country and local regulations. In France, the production and sale of products containing CBD have been authorized since December 2020, but under certain conditions.

The French decree stipulates that only hemp flowers, leaves and stems are authorized for marketing as finished products. This measure excludes raw varieties of cannabis as well as products containing THC (a psychotropic molecule). In addition, the maximum THC content must be less than 0.2% in order not to be considered a narcotic product.

However, this decision is not without controversy as some consider CBD to be a psychotropic substance that can have adverse health side effects. For example, the Belgian government has banned the use of certain plants rich in CBD due to their high THC content.

Despite this, the CBD sector continues to be permitted in many European countries with strict regulations to protect consumers. Consumers can also benefit from the potential therapeutic benefits offered by cannabidiol without experiencing the psychoactive effects associated with traditional cannabis.

In the next section, we will look in more detail at how CBD is regulated in different European countries.

What is the legalization of CBD?

CBD legalization refers to the decision by a country or region to allow the production, sale and/or use of products containing cannabidiol (CBD), a molecule extracted from hemp plants. In France, the decree published in December 2020 authorized the marketing of raw hemp leaves and flowers containing less than 0.2% tetrahydrocannabinol (THC), the psychoactive substance present in cannabis.

The move was seen as a step forward for France's emerging CBD sector, which had until now been limited by narcotics regulations. The maximum THC content is now set at 0.3% for finished products.

European regulations are also important for understanding how CBD is regulated in different countries. The European Union considers that legal varieties of hemp can be used as raw material for derived products such as CBD oil or other cosmetics based on natural extracts.

Although this new legislation may benefit consumers seeking a natural alternative to traditional medicines as well as some local French and European producers, it also raises concerns about safety and public health. Illegal or unregulated products may contain higher levels of THC or other harmful contaminants.

In summary, while French laws have changed to allow the commercial cultivation of hemp and legalize the sale of certain CBD products, it remains important for consumers to be aware of the regulations surrounding CBD. Governments have a key role to play in developing responsible legislation to protect public health while enabling a thriving CBD industry.

How is CBD regulated?

Regulation of CBD varies from country to country, and even within the same country. In France, for example, the marketing of certain varieties of cannabis such as flowers, leaves or any other part of the raw plant is prohibited. However, since December 2020, an order has authorized the sale of products containing cannabidiol (CBD) with a THC (tetrahydrocannabinol) content of less than 0.2%. Thus, consumers can buy hemp-derived products such as oils or balms containing this molecule without risking finding themselves illegal.

Also in Belgium, the production and industrial use of hemp is authorized if it meets certain conditions. Other European countries have also passed similar legislation to regulate the growing CBD market.

However, it should be noted that the exact legal status of CBD can vary depending on the interpretations of governments and local authorities. Some jurisdictions still consider CBD to be a narcotic or psychotropic product that can cause effects against public health.

Therefore, to avoid any confusion or potential infringement in this constantly evolving and complex regulation market, it is recommended that companies wishing to enter this sector be well informed about local laws regarding CBD. The French Council of State must in particular soon render a decision

Legislation in Belgium

The legislation regarding CBD in Belgium is complex and the legal situation varies depending on the different aspects of this controversial product. In Belgium, the production of industrial hemp is authorized under certain conditions, in particular a THC content of less than 0.2%. This has paved the way for increased production of products containing CBD.

However, even though hemp is legal in Belgium, the regulation of CBD remains subject to restrictions. For example, products containing CBD are considered medicines and must be registered with the Federal Agency for Medicines and Health Products (FAMHP) to be legally marketed.

It is important for consumers and businesses to stay informed about local laws before buying or selling products containing CBD in Belgium.

In Belgium, the Federal Public Service (FPS) Public Health, Food Chain Safety and Environment supervises the agricultural production of hemp as well as its marketing. The SPF ensures that all authorized varieties respect the maximum THC content tolerated by Belgian law.

Overall, Belgian CBD regulations continue to evolve rapidly. It will be important for consumers and businesses interested in this growing market to stay informed of future changes so that all can act in accordance with applicable local laws.

European legislation

European CBD legislation is complex and varies considerably between countries. In December 2020, the European Union adopted new regulations that allow the marketing of products containing cannabidiol (CBD) with a THC content of less than 0.2%.

In France, the use of cannabis flowers and raw leaves is prohibited but the sale of derivative products containing CBD has been authorized since this decision. However, French production cannot include plant varieties authorized in other countries because they are considered narcotics in France.

The French Council of State clarified that only finished products were allowed to be sold and consumed. Therefore, no raw products are legal for sale or consumption at this time.

In other European countries like Belgium, CBD products are also subject to strict regulations. THC content must be less than 0.2% to be considered legal.

You should therefore carefully check the laws of the country you are in before using or marketing CBD products to avoid any possible legal sanctions.

In the next section we will further explore how this regulation works in the United States.

Benefits of Legalizing CBD

The legalization of CBD offers many benefits for consumers, producers and the industry in general. One of the key benefits is the increased availability of products containing cannabidiol, such as oils, creams and capsules. This increased availability allows consumers to more easily access these products without having to turn to the black market.

Legalizing CBD also reduces the stigma associated with cannabis in general. People often tend to associate cannabis with the recreational use of marijuana which can have a psychotropic effect on users. The distinction between the THC contained in marijuana (which gives it its psychoactive properties) and CBD thus becomes clearer.

In addition, regulating the production and marketing of CBD will encourage more investment in this thriving industry. It could also spur a significant increase in scientific research to better understand the potential beneficial effects of cannabidiol on our health.

However, there are also disadvantages to take into account such as a total or partial absence of psychoactive effect felt by some users may consider it a negative point because they do not feel anything after taking it - but this can be positive for those who are simply looking for therapeutic benefits without wanting to feel “high”. Ultimately, each country must decide whether or not it wishes to legalize this natural molecule derived in particular from the hemp plant.


Since December 2020, the marketing of products containing cannabidiol (CBD) has been authorized in France, under certain conditions. This new legislation has opened up a thriving market for CBD producers and consumers in France. Flowers, leaves and other varieties of raw hemp plants can now be sold legally in the country.

However, it is important to note that French regulations strictly govern the production and sale of CBD. Unlike cannabis, which is considered a narcotic product prohibited by the French state, CBD is not considered a psychotropic substance devoid of harmful side effects for health.

The maximum authorized content of THC (tetrahydrocannabinol), a psychotropic molecule present in cannabis, must be less than 0.2% for CBD-based products. In addition, these products must not be presented as having therapeutic or medical properties.

Also in Belgium, the trade in CBD has been authorized under certain conditions since September 2021. However, each Member State has its own legislation on the subject within the European Union.

The legalization of CBD offers consumers a less psychoactive alternative to other products containing cannabinoids such as THC. It also allows producers and traders to benefit from an emerging economic sector while being subject to strict government regulations to ensure product safety and quality.

Stigma reduction

Legalizing CBD can help reduce the stigma associated with cannabis. While cannabis is often considered an illegal and dangerous drug, CBD is a non-psychotropic molecule that does not have the same effects as THC. By allowing the production, sale and use of products containing CBD, consumers can feel more comfortable purchasing these products without fear of being judged or criminalized.

In France, since December 2020, a decree has authorized the marketing of hemp flowers containing less than 0.2% THC. This decision was taken within the framework of European regulations aimed at harmonizing the legislation of the Member States on the varieties of plants authorized for agricultural production (including hemp).

However, it should nevertheless be emphasized that this ban still concerns all other types of narcotics derived from cannabis such as raw leaves or resin for example.

The legalization of CBD also allows for increased research into its potential therapeutic effects. French professionals thus received authorizations more easily to carry out clinical tests involving this molecule. This trend is expected to continue with the growing interest in the medical cannabis market.

The French government, however, provides for certain restrictions such as a maximum level of THC (psychoactive molecule) not to exceed 0.2% as well as rigorous regulations regarding the production and marketing of these products. Regular checks will be carried out to ensure that CBD products meet current standards while protecting consumers from potential risks associated with the use of these products.

Now that we've explored the stigma reduction associated with CBD, let's see what its benefits are.

Increased searches

One of the most significant benefits of CBD legalization is the increase in research on cannabidiol. With the ban lifted, researchers can now conduct in-depth studies on the effects of CBD on human health, both in the short and long term.

In France, this decision was taken in December 2020 with a new government decree authorizing the production and marketing of certain varieties of plants containing less than 0.2% THC. This THC content is the criterion that determines whether a plant is considered a narcotic product or not.

Thus, consumers can now purchase CBD products in France without being considered criminals. The same applies to other European countries such as Belgium where the use of cannabidiol remains authorized under certain conditions.

However, despite these new relaxed regulations regarding CBD, it is important for consumers to still exercise great caution when purchasing these products. They must ensure that their supplier complies with all applicable sales and labeling laws and regulations.

Overall, increased research will allow potential consumers to learn more about CBD and its beneficial effects for their overall health while avoiding misuse and potentially dangerous use.

The disadvantages of legalizing CBD

Despite the benefits it may provide, the legalization of CBD is not without its drawbacks.

First of all, some products containing CBD may be considered narcotics in France and other European countries, which poses a regulatory and marketing problem for producers and consumers.

Indeed, the THC content (psychotropic molecule) in certain varieties of hemp plants can exceed the authorized legal threshold and make these products illegal.

Additionally, there are potential health risks associated with using CBD. Although its side effects are generally less severe than those associated with consuming THC-containing cannabis, it can still cause adverse effects such as drowsiness or low blood pressure in some individuals.

Finally, in addition to the health risks associated with its consumption, CBD is often presented as a panacea that can cure all ills. This erroneous perception could lead some consumers to use these products to replace medications prescribed by their doctor without having been informed of the possible interactions with the latter.

It is therefore crucial for the French and European government to establish clear regulations governing the production and sale of products containing CBD in order to ensure their safety for consumers as well as the integrity of this emerging sector. The next subtitle will focus on

Conclusion on the different legislative aspects surrounding the legalization of CBD in France and the European Union.

In conclusion, the legalization of CBD in 2023 is a significant step forward for the industry.

This will allow easier access to high-quality products, reduce the stigma surrounding cannabis use, and open opportunities for additional research into the potential health benefits of CBD.

However, it is important to note that while CBD may be legal under certain conditions, products containing THC remain illegal and highly regulated.

As regulations continue to evolve around the world, it is essential for consumers and producers to monitor evolving laws and stay informed about what is permitted in their respective regions. With proper education and responsible practices, the future of the CBD industry looks bright.

Related Articles